NCT06530251 2026-03-04
A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)
Akeso
Phase 1/2 Recruiting
Akeso
ImmVirx Pty Ltd
Innovent Biologics (Suzhou) Co. Ltd.
Hutchmed
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
RemeGen Co., Ltd.